Dow Chemical Company’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q4
Sell
-239,000
Closed -$3.92M 35
2015
Q3
$3.92M Sell
239,000
-35,000
-13% -$598K 0.33% 33
2015
Q2
$4.85M Sell
274,000
-16,000
-6% -$286K 0.44% 28
2015
Q1
$5.15M Buy
290,000
+35,000
+14% +$553K 0.46% 26
2014
Q4
$3.38M Buy
255,000
+60,000
+31% +$767K 0.3% 41
2014
Q3
$2.3M Hold
195,000
0.2% 53
2014
Q2
$2.49M Hold
195,000
0.21% 58
2014
Q1
$2.64M Sell
195,000
-50,000
-20% -$656K 0.22% 49
2013
Q4
$2.94M Sell
245,000
-210,000
-46% -$2.48M 0.24% 40
2013
Q3
$5.34M Hold
455,000
0.45% 21
2013
Q2
$4.22M Buy
+455,000
New +$3.86M 0.37% 28

Other funds holding BSX

Dow Chemical Company's BSX Position: Q4 2015 in Review

Dow Chemical Company sold out of Boston Scientific (BSX) in Q4 2015, closing a stake of 239,000 shares — an estimated $3.92M sold.

Dow Chemical Company first reported a position in BSX in Q2 2013 and held it in 10 quarters. The position peaked at $5.34M in Q3 2013. 502 funds tracked by Wall St. Rank hold BSX as of Q4 2015.

  • Dow Chemical Company reported no remaining Boston Scientific position as of Q4 2015 after selling out during the quarter.
  • Dow Chemical Company sold 239,000 Boston Scientific shares in Q4 2015, an estimated $3.92M.
  • Dow Chemical Company first reported a position in Boston Scientific in Q2 2013 and held it in 10 quarters.
  • Dow Chemical Company's Boston Scientific position peaked at $5.34M in Q3 2013.
  • 502 funds tracked by Wall St. Rank held Boston Scientific as of Q4 2015.

Based on Dow Chemical Company's 13F filing for Q4 2015, filed 16 Feb 2016.